Orion Bliss (ORIB) 10-Q13 Feb 242024 Q3 Quarterly reportFinancial data

Company Profile

Cover

Cover	9 Months Ended
Cover	Jan. 31, 2024 shares
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jan. 31, 2024
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--04-30
Entity File Number	333-257326
Entity Registrant Name	ORION BLISS CORP.
Entity Central Index Key	0001854183
Entity Tax Identification Number	98-1591444
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	Kalonite 9-57
Entity Address, City or Town	Ashdod
Entity Address, Country	IL
Entity Address, Postal Zip Code	7724233
City Area Code	849
Local Phone Number	8593819
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	true
Entity Shell Company	true
Entity Common Stock, Shares Outstanding	3,038,000

Balance Sheets (Unaudited)

Balance Sheets (Unaudited) - USD ($)	Jan. 31, 2024	Apr. 30, 2023
Current Assets
Escrow Account	$ 140	$ 7,781
Website Development, net	134	134
Total Current Assets	274	7,915
Current Liabilities
Accounts payable- Related party	34,000	25,000
Director loan	48,000	19,752
Total Current Liabilities	82,000	44,752
Stockholders’ Deficit
Common stock, par value $0.0001; 75,000,000 shares authorized, 3,038,000 shares issued and outstanding respectively;	304	304
Additional paid-in capital	20,656	20,656
Accumulated deficit	(102,686)	(57,797)
Total Stockholders’ Deficit	(81,726)	(36,837)
Total Liabilities and Stockholders’ Deficit	$ 274	$ 7,915

Balance Sheets (Unaudited) (Par

Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Jan. 31, 2024	Apr. 30, 2023
Statement of Financial Position [Abstract]
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	75,000,000	75,000,000
Common Stock, Shares, Issued	3,038,000	3,038,000
Common Stock, Shares, Outstanding	3,038,000	3,038,000

Condensed Statement of Operatio

Condensed Statement of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
Condensed Statement of Operations (Unaudited) - USD ($)	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Income Statement [Abstract]
REVENUES (Consulting services)	$ 0	$ 0	$ 0	$ 600
General and Administrative Expenses	7,263	6,674	44,889	20,828
NET INCOME (LOSS) FROM OPERATION	(7,263)	(6,674)	(44,889)	(20,228)
PROVISION FOR TAXES	0	0	0	0
NET INCOME (LOSS)	$ (7,263)	$ (6,674)	$ (44,889)	$ (20,228)

Condensed Statement of Operat_2

Condensed Statement of Operations (Unaudited) (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Income Statement [Abstract]
Earnings Per Share, Basic	$ 0	$ 0	$ 0	$ 0
Earnings Per Share, Diluted	$ 0	$ 0	$ 0	$ 0
Weighted Average Number of Shares Outstanding, Basic	3,038,000	2,975,304	3,038,000	2,464,111
Weighted Average Number of Shares Outstanding, Diluted	3,038,000	2,975,304	3,038,000	2,464,111

Statements of Stockholder Equit

Statements of Stockholder Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Mar. 22, 2021	$ 0	$ 0	$ 0	$ 0
Shares, Outstanding, Beginning Balance at Mar. 22, 2021	0
Shares issued for cash at $0.02 per share in September and January 31, 2023	$ 200			200
Stock Issued During Period, Shares, New Issues	2,000,000
Net loss			(1,925)	(1,925)
Ending balance, value at Apr. 30, 2021	$ 200	0	(1,925)	(1,725)
Shares, Outstanding, Ending Balance at Apr. 30, 2021	2,000,000
Net loss			(26,690)	(26,690)
Ending balance, value at Apr. 30, 2022	$ 200	0	(28,615)	(28,415)
Shares, Outstanding, Ending Balance at Apr. 30, 2022	2,000,000
Shares issued for cash at $0.02 per share in September and January 31, 2023	$ 7	1,303		1,310
Stock Issued During Period, Shares, New Issues	65,500
Net loss			(8,636)	(8,636)
Ending balance, value at Jul. 31, 2022	$ 207	1,303	(37,251)	(35,741)
Shares, Outstanding, Ending Balance at Jul. 31, 2022	2,065,500
Shares issued for cash at $0.02 per share in September and January 31, 2023	$ 82	16,368		16,450
Stock Issued During Period, Shares, New Issues	822,500
Net loss			(5,521)	(5,521)
Ending balance, value at Oct. 31, 2022	$ 289	17,671	(42,169)	(24,209)
Shares, Outstanding, Ending Balance at Oct. 31, 2022	2,888,000
Shares issued for cash at $0.02 per share in September and January 31, 2023	$ 15	2,985		3,000
Stock Issued During Period, Shares, New Issues	150,000
Net loss			(6,674)	(6,674)
Ending balance, value at Jan. 31, 2023	$ 304	20,656	(48,843)	(27,883)
Shares, Outstanding, Ending Balance at Jan. 31, 2023	3,038,000
Net loss			(8,954)	(8,954)
Ending balance, value at Apr. 30, 2023	$ 304	20,656	(57,797)	(36,837)
Shares, Outstanding, Ending Balance at Apr. 30, 2023	3,038,000
Net loss			(33,623)	(33,623)
Ending balance, value at Jul. 31, 2023	$ 304	20,656	(91,420)	(70,460)
Shares, Outstanding, Ending Balance at Jul. 31, 2023	3,038,000
Net loss			(4,003)	(4,003)
Ending balance, value at Oct. 31, 2023	$ 304	20,656	(95,423)	(74,463)
Shares, Outstanding, Ending Balance at Oct. 31, 2023	3,038,000
Net loss			(7,263)	(7,263)
Ending balance, value at Jan. 31, 2024	$ 304	$ 20,656	$ (102,686)	$ (81,726)
Shares, Outstanding, Ending Balance at Jan. 31, 2024	3,038,000

Condensed Statement of Cash Flo

Condensed Statement of Cash Flows (Unaudited) - USD ($)	9 Months Ended
Condensed Statement of Cash Flows (Unaudited) - USD ($)	Jan. 31, 2024	Jan. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss) for the period	$ (44,889)	$ (20,228)
Adjustments to reconcile net loss to net cash used in operating activities:
Website Development	0	0
Changes in assets and liabilities:
CASH FLOWS USED IN OPERATING ACTIVITIES	(44,889)	(20,228)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuing common stock at $0.02 per share	0	20,760
Accounts Payable- Related Party	9,000	9,000
Related Party loans	28,248	4,203
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES	37,248	33,963
Net Cash Increase (Decrease) for Period	(7,641)	13,735
Cash at the beginning of Period	7,781
Cash at end of Period	140	13,735
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid	0	0
Income taxes paid	$ 0	$ 0

ORGANIZATION AND NATURE OF BUSI

ORGANIZATION AND NATURE OF BUSINES	9 Months Ended
ORGANIZATION AND NATURE OF BUSINES	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND NATURE OF BUSINES	Note 1 – ORGANIZATION AND NATURE OF BUSINES Orion Bliss Corp. (referred as the “Company”, “we”, “our”) was Incorporated in the State of Nevada and established on March 23, 2021. We are a development-stage company formed to commence operations related to selling Milk_shake hairline products. We have website which is being developed at http://orionbliss.co.il. Our office is located at Kalonite 9-57, Ashdod, Israel, zip code 7724233.

GOING CONCERN

GOING CONCERN	9 Months Ended
GOING CONCERN	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	Note 2 – GOING CONCERN The accompanying financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”), which contemplate continuation of the Company as a going concern. The Company has an accumulated deficit of $ 102,686 57,797

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Jan. 31, 2024
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Note 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation The accompanying unaudited condensed financial statements have been prepared in accordance with the rules and regulations (Regulation S-X) of the Securities and Exchange Commission (the “SEC”) and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the three and nine-months ended January 31, 2024, are not necessarily indicative of the operating results that may be expected for the year ending April 30, 2023. These unaudited condensed financial statements should be read in conjunction with the April 30, 2023, financial statements and notes thereto. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Deferred Offering Costs Financial Accounting Standard Board Accounting Standards Codification number 340-10-S99-1, Other Assets and Deferred Costs Cash and Cash Equivalents The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents. Fair Value of Financial Instruments Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820 “Fair Value Measurement” defines fair value as the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The standards apply to recurring and nonrecurring fair value measurements of financial and non-financial assets and liabilities. The Company determines the fair values of its assets and liabilities based on a fair value hierarchy that includes three levels of inputs that may be used to measure fair value. For the three levels are defined as follows: Level 1: defined as observable inputs such as quoted prices in active markets; Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. Due to its short-term nature, the carrying value of receivables, accounts payable, and advances approximated fair value at January 31, 2024. Income Taxes Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. Long-Lived Assets – Intangible Assets We account for our intangible assets in accordance with ASC Subtopic 350-30, General Intangibles Other Than Goodwill, and ASC Subtopic 360-10-05, Accounting for the Impairment or Disposal of Long-Lived Assets. ASC Subtopic 350-30 requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Further, ASC Subtopic 350-30 requires an intangible asset to be amortized over its useful life and for the useful life to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs of internally developing, maintaining, or restoring intangible assets are recognized as an expense when incurred. Basic Income (Loss) Per Share The Company computes income (loss) per share in accordance with FASB ASC 260 “Earnings per Share.” Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. As of January 31, 2024, there were no Recent Accounting Pronouncements We have reviewed all the recently issued, but not yet effective, accounting pronouncements and we do not believe any of these pronouncements will have a material impact on the Company. Risks and Uncertainties In December 2020, a novel strain of coronavirus (COVID-19) emerged in Wuhan, Hubei Province, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to several other countries and infections have been reported globally. The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but is anticipated to have a material adverse impact on our business, financial condition and results of operations. Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company’s business and the duration for which it may have an impact cannot be determined at this time. Financial Statement Reclassification Certain account balances from prior periods have been reclassified in these financial statements to conform to current period classifications.

COMMON STOCK

COMMON STOCK	9 Months Ended
COMMON STOCK	Jan. 31, 2024
Equity [Abstract]
COMMON STOCK	Note 4 – COMMON STOCK The Company has 75,000,000 0.0001 On April 15, 2022 the Company issued 2,000,000 200 In July, 2023, the Company issued 65,500 1,310 In September and January 2023, the Company issued 822,500 16,450 In November and December 2022 followed by January 2023, the Company issued 150,000 3,000 There were 3,038,000 Voting Common Stock All shares of common stock have voting rights and are identical. All holders of shares of voting common stock shall at every meeting of the stockholders be entitled to one vote for each share of the capital stock held by such stockholder. Non-voting Common Stock All of the other terms of the Non-Voting Common Stock shall be identical to the Voting Common Stock, except for the right of first refusal that attaches to the Non-Voting Common Stock, as explained in the Company’s Bylaws.

INCOME TAXES

INCOME TAXES	9 Months Ended
INCOME TAXES	Jan. 31, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	Note 5 – INCOME TAXES On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (“Tax Reform Act”). The legislation significantly changes U.S. tax law by, among other things, lowering corporate income tax rates, implementing a territorial tax system and imposing a transition tax on deemed repatriated earnings of foreign subsidiaries. The Tax Reform Act permanently reduces the U.S. corporate income tax rate from a maximum of 35% to a flat 21% rate, effective January 1, 2018. The reconciliation of income tax benefit (expenses) at the U.S. statutory rate at 21% for the period ended as follows: Schedule of income tax benefit (expenses) January 31, 2024 Tax benefit (expenses) at U.S. statutory rate $ (1,525 ) Change in valuation allowance 1,525 Tax benefit (expenses), net $ – The tax effects of temporary differences that give rise to significant portions of the net deferred tax assets are as follows: Schedule of deferred tax assets January 31, 2024 Net operating loss $ (21,564 ) Valuation allowance 21,564 Deferred tax assets, net $ – The Company has accumulated approximately $ 102,686

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
COMMITMENTS AND CONTINGENCIES	Jan. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	Note 6 – COMMITMENTS AND CONTINGENCIES Our sole officer and director, Alexandra Solomovskaya, has agreed to provide her own premise under office needs. She will not take any fee for these premises it is for free use. Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company’s business and the duration for which it may have an impact cannot be determined at this time.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
SUBSEQUENT EVENTS	Jan. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	Note 7 – SUBSEQUENT EVENTS In accordance with ASC 855-10 the Company has analyzed its operations subsequent to January 31, 2024 to the date these financial statements were issued, and has determined that it does not have any material subsequent events to disclose in these financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Jan. 31, 2024
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation The accompanying unaudited condensed financial statements have been prepared in accordance with the rules and regulations (Regulation S-X) of the Securities and Exchange Commission (the “SEC”) and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the three and nine-months ended January 31, 2024, are not necessarily indicative of the operating results that may be expected for the year ending April 30, 2023. These unaudited condensed financial statements should be read in conjunction with the April 30, 2023, financial statements and notes thereto.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Deferred Offering Costs	Deferred Offering Costs Financial Accounting Standard Board Accounting Standards Codification number 340-10-S99-1, Other Assets and Deferred Costs
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820 “Fair Value Measurement” defines fair value as the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The standards apply to recurring and nonrecurring fair value measurements of financial and non-financial assets and liabilities. The Company determines the fair values of its assets and liabilities based on a fair value hierarchy that includes three levels of inputs that may be used to measure fair value. For the three levels are defined as follows: Level 1: defined as observable inputs such as quoted prices in active markets; Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. Due to its short-term nature, the carrying value of receivables, accounts payable, and advances approximated fair value at January 31, 2024.
Income Taxes	Income Taxes Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.
Long-Lived Assets – Intangible Assets	Long-Lived Assets – Intangible Assets We account for our intangible assets in accordance with ASC Subtopic 350-30, General Intangibles Other Than Goodwill, and ASC Subtopic 360-10-05, Accounting for the Impairment or Disposal of Long-Lived Assets. ASC Subtopic 350-30 requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Further, ASC Subtopic 350-30 requires an intangible asset to be amortized over its useful life and for the useful life to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs of internally developing, maintaining, or restoring intangible assets are recognized as an expense when incurred.
Basic Income (Loss) Per Share	Basic Income (Loss) Per Share The Company computes income (loss) per share in accordance with FASB ASC 260 “Earnings per Share.” Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. As of January 31, 2024, there were no
Recent Accounting Pronouncements	Recent Accounting Pronouncements We have reviewed all the recently issued, but not yet effective, accounting pronouncements and we do not believe any of these pronouncements will have a material impact on the Company.
Risks and Uncertainties	Risks and Uncertainties In December 2020, a novel strain of coronavirus (COVID-19) emerged in Wuhan, Hubei Province, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to several other countries and infections have been reported globally. The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but is anticipated to have a material adverse impact on our business, financial condition and results of operations. Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company’s business and the duration for which it may have an impact cannot be determined at this time.
Financial Statement Reclassification	Financial Statement Reclassification Certain account balances from prior periods have been reclassified in these financial statements to conform to current period classifications.

INCOME TAXES (Tables)

INCOME TAXES (Tables)	9 Months Ended
INCOME TAXES (Tables)	Jan. 31, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES (Details - Income tax expense)	Schedule of income tax benefit (expenses) January 31, 2024 Tax benefit (expenses) at U.S. statutory rate $ (1,525 ) Change in valuation allowance 1,525 Tax benefit (expenses), net $ –
INCOME TAXES (Details - Deferred taxes)	Schedule of deferred tax assets January 31, 2024 Net operating loss $ (21,564 ) Valuation allowance 21,564 Deferred tax assets, net $ –

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	Jan. 31, 2024	Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Retained Earnings (Accumulated Deficit)	$ 102,686	$ 57,797

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	9 Months Ended
	Jan. 31, 2024 shares
Accounting Policies [Abstract]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0

COMMON STOCK (Details Narrative

COMMON STOCK (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended	5 Months Ended	9 Months Ended
COMMON STOCK (Details Narrative) - USD ($)	Apr. 15, 2022	Jul. 31, 2023	Jan. 31, 2023	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023	Apr. 30, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common Stock, Shares Authorized					75,000,000		75,000,000
Common Stock, Par or Stated Value Per Share					$ 0.0001		$ 0.0001
Proceeds from Issuance of Common Stock					$ 0	$ 20,760
Common Stock, Shares, Issued					3,038,000		3,038,000
Director [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock Issued During Period, Shares, Issued for Services	2,000,000
Stock Issued During Period, Value, Issued for Services	$ 200
Three Shareholders [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock Issued During Period, Shares, New Issues		65,500
Proceeds from Issuance of Common Stock		$ 1,310
Twenty Nine Shareholders [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock Issued During Period, Shares, New Issues				822,500
Proceeds from Issuance of Common Stock				$ 16,450
Five Shareholders [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock Issued During Period, Shares, New Issues			150,000
Proceeds from Issuance of Common Stock			$ 3,000

INCOME TAXES (Details - Income

INCOME TAXES (Details - Income tax expense) - USD ($)	3 Months Ended		9 Months Ended
INCOME TAXES (Details - Income tax expense) - USD ($)	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Income Tax Disclosure [Abstract]
Tax benefit (expenses) at U.S. statutory rate			$ (1,525)
Change in valuation allowance			1,525
Tax benefit (expenses), net	$ 0	$ 0	$ 0	$ 0

INCOME TAXES (Details - Deferre

INCOME TAXES (Details - Deferred taxes)	Jan. 31, 2024 USD ($)
Income Tax Disclosure [Abstract]
Net operating loss	$ (21,564)
Valuation allowance	21,564
Deferred tax assets, net

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative)	Jan. 31, 2024 USD ($)
Income Tax Disclosure [Abstract]
Operating Loss Carryforwards	$ 102,686